参考文献/References:
[1] American Thyroid Association(ATA)Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2009, 19(1):1167-1214.
[2] Sherman SI. Thyroid carcinoma,Lancet,2003,361(9356):501-511.
[3] Rosário PW, de Faria S, Bicalho L, et al. Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma[J]. J Ultrasound Med, 2005, 24(10):1385-1389.
[4] Kim DW, Choo HJ, Lee YJ, et al. Sonographic features of cervical lymph nodes after thyroidectomy for papillary thyroid carcinoma[J]. J Ultrasound Med. 2013:32(7),1173-1180.
[5] Sohn YM, Kwak JY, Kim EK, et al. Diagnostic approach for evaluation of lymph node metastasis from thyroid cancer using ultrasound and fine-needle aspiration biopsy[J]. AJR Am J Roentgenol, 2010,194(1):38-43.
[6] Yuasa K, Kawazu T, Nagata T, et al. Computed tomography and ultrasonography of metastatic cervical lymph nodes in oral squamous cell carcinoma[J]. Dentomaxillofac Radiol, 2000, 29(4):238-244.
[7] Steinkamp HJ, Cornehl M, Hosten N, et al. Cervical lymphadenopathy:ratio of long-to short-axis diameter as a predictor of malignancy[J]. Br J Radiol, 1995, 68 (807):266-270.
[8] Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer[J]. Laryngoscope, 2011, 121(3):487-491.
[9] Ariba? BK, Arda K, ?ileda? N, et al. Predictive factors for detecting malignancy in central and lateral cervical lymph nodes in papillary carcinoma of the thyroid[J]. Asia Pac J Clin Oncol, 2011, 7(3):307-314.
[10] Lee YH, Lee NJ, Kim JH, et al. US diagnosis of cervical recurrence in patients operated on thyroid cancer:sonographic features and clinical significance[J]. Auris Nasus Larynx, 2007, 34(2):213-219.
[11] Langer JE, Mandel SJ. Sonographic imaging of cervical lymph nodes in patients with thyroid cancer[J]. Neuroimaging Clin N Am, 2008, 18(3):479-489.
[12] Saindane AM. Pitfalls in the staging of cervical lymph node metastasis[J]. Neuroimaging Clin N Am, 2013, 23(1):147-166.
[13] Layfield LJ. Fine-needle aspiration in the diagnosis of head and neck lesions:a review and discussion of problems in differential diagnosis[J]. Diagn Cytopathol, 2007, 35(12):798-805.
[14] Frasoldati A, Toschi E, Zini M, et al. Role of thyroglobulin measurement in fine-needle aspiration biopsies of cervical lymph nodes in patients with differentiated thyroid cancer[J]. Thyroid, 1999, 9(2):105-111.
[15] Kim MJ, Kim EK, Kim BM, et al. Thyroglobulin measurement in fine-needle aspirate washouts:the criteria for neck node dissection for patients with thyroid cancer[J]. Clin Endoerinol (Oxf), 2009,70(1):145-151.
[16] Ariba? BK, Arda K, Cileda? N, et al. Fine-needle aspiration biopsy of cervical lymph nodes:factors in predicting malignant diagnosis[J]. Neoplasma, 2011, 58(1):51-57.
[17] Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium[J]. Eur J Endocrinol, 2006, 154(6):787-803.
[18] Kloos RT, Mazzaferri EL. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later[J]. J Clin Endocrinol Metab, 2005, 90(9):5047-5057.
[19] Kaneko K, Abe K, Baba S, et al. Can calcification predict 131I accu- mulation on metastatic lymph nodes in papillary thyroid carcinoma patients receiving 131I therapy? Comparison of CT, 131I WBS and 18F-FDG PET/CT[J]. Eur Radiol, 2010, 20(2):477-483.
[20] Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension[J]. Thyroid, 2012, 22(11):1144-1152.
[21] Rondeau G, Fish S, Hann LE, et al. Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression[J]. Thyroid, 2011, 21(8):845-853.
[22] Robenshtok E, Fish S, Bach A, et al. Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usu- ally remain stable over years in properly selected patients[J]. J Clin Endocrinol Metab, 2012, 97(8):2706-2713.
[23] Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary mierocarcinoma of the thyroid[J]. Thyroid, 2003, 13(4):381-387.
[24] Ito Y, Miyauehi A, Inoue H, et al. An observational trial for papillary thyroid mieroearcinoma in Japanese patients[J]. World J Surg, 2010,34(1):28-35.
[25] Sugitani I, Toda K, Yamada K, et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized:our treatment strategies and outcomes[J]. World J Surg, 2010, 34(6):1222-1231.
相似文献/References:
[1]李盼丽,宋少莉.碘难治性分化型甲状腺癌靶向药物治疗进展[J].国际放射医学核医学杂志,2016,40(3):202.[doi:10.3760/cma.j.issn.1673-4114.2016.03.009]
Li Panli,Song Shaoli.Radioactive iodine refractory differentiated thyroid cancer targeted therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):202.[doi:10.3760/cma.j.issn.1673-4114.2016.03.009]
[2]杨珂,唐波,于夕荣,等.甲状腺癌131i治疗病房的辐射屏蔽计算与评价[J].国际放射医学核医学杂志,2015,39(5):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
yang ke,tang bo,yu xirong,et al.shielding calculation and assessment in 131i therapy for thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
[3]陈立,陈跃.分化型甲状腺癌骨转移诊断及疗效评价的核素显像研究进展[J].国际放射医学核医学杂志,2016,40(6):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
Chen Li,Chen Yue.Diagnosis and evaluation of curative effect progress of radionuclide imaging methods in differentiated thyroid cancer of bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
[4]周金鑫,张一帆.胰岛细胞移植监测的分子影像学进展[J].国际放射医学核医学杂志,2015,39(6):478.[doi:10.3760/cma.j.issn.1673-4114.2015.06.009]
Zhou Jinxin,Zhang Yifan.Research progress of molecular imaging in monitoring islet transplantation[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):478.[doi:10.3760/cma.j.issn.1673-4114.2015.06.009]
[5]惠金子,赵德善.Tg、TgAb及TSH在分化型甲状腺癌术前的预测分析[J].国际放射医学核医学杂志,2015,39(2):110.[doi:10.3760/cma.j.issn.1673-4114.2015.02.002]
Hui Jinzi,Zhao Deshan.The prediction of risk of differentiated thyroid carcinoma with preoperative serum thyroid stimulating hormone, thyrogiobulin and antithyroglobulin antibody[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):110.[doi:10.3760/cma.j.issn.1673-4114.2015.02.002]
[6]刘斌,潘明志.BRAF基因突变对甲状腺乳头状癌诊治价值的研究进展[J].国际放射医学核医学杂志,2015,39(2):154.[doi:10.3760/cma.j.issn.1673-4114.2015.02.011]
Liu Bin,Pan Mingzhi.Advances in value of BRAF gene mutation on the diagnosis and treatment of papillary thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):154.[doi:10.3760/cma.j.issn.1673-4114.2015.02.011]
[7]张跃鹏,田月丽,郑齐超.超声误诊阑尾黏液囊肿一例[J].国际放射医学核医学杂志,2015,39(2):188.[doi:10.3760/cma.j.issn.1673-4114.2015.02.019]
[8]林翠君,李丽红,陈惠莲,等.乳腺非典型增生的综合影像学表现[J].国际放射医学核医学杂志,2015,39(3):216.[doi:10.3760/cma.j.issn.1673-4114.2015.03.006]
Lin Cuijun,Li Lihong,Chen Huilian,et al.Imaging features of digital mammography and sonography on mammary atypical hyperplasia[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):216.[doi:10.3760/cma.j.issn.1673-4114.2015.03.006]
[9]胡斌,王锦锋,毛秋粉.18F-FDG PET/CT显像在Tg阳性131I全身显像阴性的分化型甲状腺癌患者中的应用价值[J].国际放射医学核医学杂志,2015,39(3):242.[doi:10.3760/cma.j.issn.1673-4114.2015.03.012]
Hu Bin,Wang Jinfeng,Mao Qiufen.The application value of 18F-FDG PET/CT in patients with differentiated thyroid cancer of high thyroglobulin level and negative 131I whole body scan[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):242.[doi:10.3760/cma.j.issn.1673-4114.2015.03.012]
[10]张晖,段清,卓娜,等.经直肠超声引导下“6+X”点法前列腺穿刺活检诊断前列腺癌的临床价值分析[J].国际放射医学核医学杂志,2015,39(4):308.[doi:10.3760/cma.j.issn.1673-4114.2015.04.008]
Zhang Hui,Duan Qing,Zhuo Na,et al.Meta-analysis of the diagnostic value of transrectal ultrasound-guided “6+X” points biopsy in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):308.[doi:10.3760/cma.j.issn.1673-4114.2015.04.008]
[11]冯学民.甲状腺癌的影像学研究进展[J].国际放射医学核医学杂志,2006,30(5):275.
FENG Xue-min.Advances in imaging diagnosis of thyroid carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):275.